Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2011.06.014DOI Listing

Publication Analysis

Top Keywords

valve-in-valve direct
4
direct transaortic
4
transaortic corevalve
4
corevalve implantation
4
implantation insufficient
4
insufficient sapien
4
sapien valve
4
valve-in-valve
1
transaortic
1
corevalve
1

Similar Publications

Bioprosthetic aortic valve degeneration (BAVD) is a significant clinical concern following both transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR). The increasing use of bioprosthetic valves in aortic valve replacement in younger patients and the subsequent rise in cases of BAVD are acknowledged in this review which aims to provide a comprehensive overview of the incidence, diagnosis, predictors, and management of BAVD. Based on a thorough review of the existing literature, this article provides an updated overview of the biological mechanisms underlying valve degeneration, including calcification, structural deterioration, and inflammatory processes and addresses the various risk factors contributing to BAVD, such as patient demographics, comorbidities, and procedural variables.

View Article and Find Full Text PDF

Aortic Valve-in-Valve Procedures: Challenges and Future Directions.

J Clin Med

August 2024

Ramsay Générale de Santé, Institut Cardiovasculaire Paris Sud, 6 Avenue du Noyer Lambert, 91100 Massy, France.

Aortic valve-in-valve (ViV) procedures are increasingly performed for the treatment of surgical bioprosthetic valve failure in patients at intermediate to high surgical risk. Although ViV procedures offer indisputable benefits in terms of procedural time, in-hospital length of stay, and avoidance of surgical complications, they also present unique challenges. Growing awareness of the technical difficulties and potential threats associated with ViV procedures mandates careful preprocedural planning.

View Article and Find Full Text PDF

Background: Mitral annular calcification (MAC) is common in the elderly. Extensive calcification has been historically challenging for the cardiac surgeons, with traditional surgical approaches carrying significant risks. Less invasive approaches have recently been explored in an attempt to reduce this risk.

View Article and Find Full Text PDF
Article Synopsis
  • Transcatheter mitral valve-in-valve replacement is a less invasive option for high-risk patients with failed bioprosthetic mitral valves, and this study focuses on its outcomes in intermediate-risk patients.
  • A total of 50 patients, mostly around 70 years old, were treated using a balloon-expandable valve, and results showed no deaths or strokes within one year post-procedure.
  • The procedure led to significant improvement in patients' symptoms and quality of life, with most experiencing low levels of mitral regurgitation and overall better heart function after one year.
View Article and Find Full Text PDF

Leaflet modification with the ShortCut™ device to prevent coronary artery obstruction during TAVR.

Cardiovasc Revasc Med

August 2024

Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, USA. Electronic address:

Article Synopsis
  • Transcatheter heart valve (THV) procedures, particularly valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR), need careful planning to avoid life-threatening coronary artery obstruction (CAO).
  • Despite using imaging and known predictors, predicting CAO remains uncertain.
  • The ShortCut™ device is designed to modify heart valve leaflets during TAVR to reduce the risk of CAO, and this review discusses its objectives, design, procedures, clinical data, and future applications.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!